The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease : Perspectives from the Research Roundtable
(2018) In Alzheimer's and Dementia 14(4). p.563-575- Abstract
The Alzheimer's Association's Research Roundtable met in November 2017 to explore the new National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease. The meeting allowed experts in the field from academia, industry, and government to provide perspectives on the new National Institute on Aging and the Alzheimer's Association Research Framework. This review will summarize the “A, T, N System” (Amyloid, Tau, and Neurodegeneration) using biomarkers and how this may be applied to clinical research and drug development. In addition, challenges and barriers to the potential adoption of this new framework will be discussed. Finally, future directions for research will be proposed.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2929e9a8-c003-4f92-860b-f362f6777667
- author
- organization
- publishing date
- 2018-04-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Alzheimer's disease, Amyloid, Biomarkers, Clinical trials, Neurodegeneration, Tau
- in
- Alzheimer's and Dementia
- volume
- 14
- issue
- 4
- pages
- 13 pages
- publisher
- Wiley
- external identifiers
-
- scopus:85044929982
- pmid:29653607
- ISSN
- 1552-5260
- DOI
- 10.1016/j.jalz.2018.03.002
- language
- English
- LU publication?
- yes
- id
- 2929e9a8-c003-4f92-860b-f362f6777667
- date added to LUP
- 2018-04-19 15:55:29
- date last changed
- 2024-09-17 19:54:57
@article{2929e9a8-c003-4f92-860b-f362f6777667, abstract = {{<p>The Alzheimer's Association's Research Roundtable met in November 2017 to explore the new National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease. The meeting allowed experts in the field from academia, industry, and government to provide perspectives on the new National Institute on Aging and the Alzheimer's Association Research Framework. This review will summarize the “A, T, N System” (Amyloid, Tau, and Neurodegeneration) using biomarkers and how this may be applied to clinical research and drug development. In addition, challenges and barriers to the potential adoption of this new framework will be discussed. Finally, future directions for research will be proposed.</p>}}, author = {{Knopman, David S. and Haeberlein, Samantha Budd and Carrillo, Maria C. and Hendrix, James A. and Kerchner, Geoff and Margolin, Richard and Maruff, Paul and Miller, David S. and Tong, Gary and Tome, Maria B. and Murray, Melissa E. and Nelson, Peter T. and Sano, Mary and Mattsson, Niklas and Sultzer, David L. and Montine, Thomas J. and Jack, Clifford R. and Kolb, Hartmuth and Petersen, Ronald C. and Vemuri, Prashanthi and Canniere, Megan Zoschg and Schneider, Julie A. and Resnick, Susan M. and Romano, Gary and van Harten, Argonde Corien and Wolk, David A. and Bain, Lisa J. and Siemers, Eric}}, issn = {{1552-5260}}, keywords = {{Alzheimer's disease; Amyloid; Biomarkers; Clinical trials; Neurodegeneration; Tau}}, language = {{eng}}, month = {{04}}, number = {{4}}, pages = {{563--575}}, publisher = {{Wiley}}, series = {{Alzheimer's and Dementia}}, title = {{The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease : Perspectives from the Research Roundtable}}, url = {{http://dx.doi.org/10.1016/j.jalz.2018.03.002}}, doi = {{10.1016/j.jalz.2018.03.002}}, volume = {{14}}, year = {{2018}}, }